Printer Friendly

Dr. Jerry I. Jacobson, Founder of Jacobson Resonance Enterprises, Inc. (OTC-BB-JRSE) Spearheads Opening of Canadian Bio Resonance Pain Relief Centers.

BOYNTON BEACH, Fla., July 10 /PRNewswire/ --

Dr. Jerry I. Jacobson, Founder, Chairman of the Board, and Chief Science & Technology Officer of Jacobson Resonance Enterprises, Inc. (OTC Bulletin Board: JRSE), is in Winnipeg, Canada, this week to spearhead the promotion of Jacobson Resonance technology that Health Canada has licensed for the treatment of chronic pain. Dr. Jacobson will be providing advanced training and treatment of select clients at Winnipeg's new Bio Resonance Pain Relief Centre.

"I'm very glad to be in Winnipeg to meet the community," says Dr. Jacobson. "There is a lot of opportunity for JRSE (OTC-BB-JRSE) in Canada that we are developing from our Bio Resonance Technology, Inc. Winnipeg head office."

Jacobson Resonators are currently in use relieving the chronic pain of arthritis at the Winnipeg Centre. Calgary, Vancouver and Montreal will be the next Canadian cities where treatments will be available this year. All Canadian technicians will be trained in the operation of Jacobson Resonators at Bio Resonance Technology, Inc. in Winnipeg.

"We are using Jacobson Resonators to safely and effectively alleviate pain without the use of drugs or surgery," says Alan Kotowich, President of Bio Resonance Technology, Inc. "Dr. Jacobson is the world-renowned expert in the field of bioelectromagnetic resonance, and we are delighted to be bringing the pain relief benefits of his patented new technology to Canadians." Jacobson Resonators are also approved (CE-Mark) for use in the European Union.

Bio Resonance Technology, Inc. is hosting a conference on the evening of Thursday, July 12, 2001, for members of Winnipeg's medical community who have indicated an interest in learning more about the science behind Dr. Jerry I. Jacobson's clinically proven technology. This event will also be attended by a number of medical professionals from outside the province where Jacobson Resonators are scheduled to begin treating people who suffer pain from Arthritic conditions.

Bio Resonance Technology, Inc., whose mission is to improve the quality of life of Canadians using Jacobson Resonance Technology, is the Canadian licensee of Jacobson Resonance Enterprises, Inc. (OTC-BB-JRSE).

Alfonso Serrato, President and CEO of Jacobson Resonance Enterprises, Inc., said, "I am very happy to announce that both the European and Canadian commercial initiatives are progressing quite well, ahead of expectations. We are well on our way to meeting revenue expectations and placing JRSE as the world leader in bioelectromagnetics and the premier company in the eradication of human suffering."

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The matters covered by such forward-looking statements are subject to known and unknown risks, uncertainties and other factors which may cause actual results, performance or achievements of the Company to differ materially from those contemplated or implied by such forward-looking statements. For further information, contact Frank Chaviano at (561) 752-4141.

COPYRIGHT 2001 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2001 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jul 10, 2001
Previous Article:Delta SkyMiles Members Can Use Miles for Savings on Delta Vacations Packages; Airline Shows Appreciation for 20 Years of Frequent Flyer Loyalty.
Next Article:Altrinsic Global Advisors announces addition of Mason Rees.

Terms of use | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters